ALXN2050

· Alexion Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for ALXN2050, covering 2024-06-06 to 2025-10-15. Get the full timeline:

Most recent: Clinical Trial Update: Study of ALXN2050 in Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN) [Phase 2]